EGFR and breast carcinoma: Although paclitaxel-mediated increases in the expression of some oncogenes have been previously reported in both human patients with breast cancer [46] and experimental breast cancer models [47], this is the first study that analyzed co-expression of BRCA1-IRIS and ErbB family members.